S68C (p.Ser68Cys) variant of AGT (Angiotensinogen)

S68C (p.Ser68Cys) in AGT (Angiotensinogen) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.44 / 1. The record also includes structural context.

S68C (p.Ser68Cys) variant details